Loomis, Sayles & Company
HAE icon

Loomis, Sayles & Company’s Haemonetics HAE Stock Holding History

Loomis, Sayles & Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-154,247
Closed -$12.4M – 743
2025
Q4 		$12.4M Sell
154,247
-70,089
-31% -$4.71M 0.01% 324
2025
Q3 		$10.9M Buy
224,336
+6,688
+3% +$414K 0.01% 345
2025
Q2 		$16.2M Buy
217,648
+21,867
+11% +$1.45M 0.02% 274
2025
Q1 		$12.4M Buy
195,781
+31,925
+19% +$2.17M 0.02% 321
2024
Q4 		$12.8M Hold
163,856
– – 0.02% 335
2024
Q3 		$13.2M Buy
163,856
+12,310
+8% +$994K 0.02% 321
2024
Q2 		$12.5M Buy
151,546
+125,464
+481% +$11M 0.02% 324
2024
Q1 		$2.23M Buy
+26,082
New +$2.05M ﹤0.01% 446
2019
Q2 		– Sell
-100,637
Closed -$8.8M – 642
2019
Q1 		$8.8M Buy
100,637
+364
+0.4% +$33.1K 0.02% 371
2018
Q4 		$10M Buy
100,273
+100,161
+89,429% +$10.5M 0.02% 318
2018
Q3 		$13K Buy
+112
New +$11.6K ﹤0.01% 777
2018
Q1 		– Sell
-710
Closed -$41K – 896
2017
Q4 		$41K Buy
710
+26
+4% +$1.37K ﹤0.01% 628
2017
Q3 		$31K Sell
684
-89
-12% -$3.7K ﹤0.01% 687
2017
Q2 		$31K Buy
+773
New +$31.7K ﹤0.01% 684
2017
Q1 		– Sell
-770
Closed -$31K – 986
2016
Q4 		$31K Buy
+770
New +$29K ﹤0.01% 713
2014
Q2 		– Sell
-85,376
Closed -$2.78M – 762
2014
Q1 		$2.78M Buy
+85,376
New +$3.26M 0.01% 561

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Loomis, Sayles & Company's HAE Position: Q1 2026 in Review

Loomis, Sayles & Company sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 154,247 shares — an estimated $12.4M sold.

Loomis, Sayles & Company first reported a position in HAE in Q1 2014 and held it in 16 quarters. The position peaked at $16.2M in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Loomis, Sayles & Company reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Loomis, Sayles & Company sold 154,247 Haemonetics shares in Q1 2026, an estimated $12.4M.
  • Loomis, Sayles & Company first reported a position in Haemonetics in Q1 2014 and held it in 16 quarters.
  • Loomis, Sayles & Company's Haemonetics position peaked at $16.2M in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.